LA VALUTAZIONE DEL RISCHIO CHIRURGICO. Paolo Caraceni
|
|
- Rosaline Sutton
- 7 years ago
- Views:
Transcription
1 MONOTEMATICA AISF 2014 Cirrosi epatica: Napoli 10 anni dopo. Napoli, 8-10 Ottobre 2014 LA VALUTAZIONE DEL RISCHIO CHIRURGICO Paolo Caraceni Dipartimento di Scienze Mediche e Chirurgiche Centro di Ricerca Biomedica Applicata (CRBA) Alma Mater Studiorum Università di Bologna
2 Prof. Paolo Caraceni Alma Mater Studiorum Università di Bologna Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d interesse in relazione a questa presentazione e che la presentazione non contiene discussione di farmaci in studio o ad uso off-label
3 CLINICAL SCENARIO 68 years old, Child B8, transient jaundice, gallbladder stones Refraining elective surgery Perform colecistectomy Obstructive jaundice Cholangitis What will kill this patient first: cirrhosis or stones? Which is the risk related to each choice? Acute on Chronic Liver Failure Emergent surgery/endoscopy? (higher risk)
4 CAN LITERATURE HELP US? YES.. BUT WITH MANY LIMITATIONS Most retrospective studies Rare randomized clinical trials Small sample size Selected populations (mostly Child-Pugh A and low MELD) Low-level evidences
5 PATIENT TYPE OF SURGERY PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY EXPERTISE OF THE SURGICAL AND MEDICAL TEAM
6 PATIENT PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY
7 SURGICAL RISK IN CIRRHOTIC PATIENTS PATIENT S VARIABLES LIVER DISEASE SEVERITY CO-MORBIDITIES AGE
8 CHRONIC LIVER DISEASE NATURAL HISTORY ASYMPTOMATIC PHASE SYMPTOMATIC PHASE HBV ETOH PORTAL HYPERTENSION CIRCULATORY DYSFUNCTION PRO-INFLAMMATORY STATE NASH HCV OTHERS jaundice ascites variceal bleeding hepatic encephalopathy bacterial infection HCC OLT DEATH CHRONIC HEPATITIS COMPENSATED CIRRHOSIS DECOMPENSATED CIRRHOSIS
9 PROGNOSTIC SCORES IN CIRRHOSIS CHILD-PUGH MELD MELD-BASED INDICES
10 PREDICTION OF SURGICAL RISK IN CIRRHOSIS CHILD-PUGH SCORE 100 POST-OPERATIVE MORTALITY (%) A B C Child-Pugh class De Goede et al., Best Pract Res Clin Gastroenterol, 2012
11 PREDICTION OF SURGICAL RISK IN CIRRHOSIS CHILD-PUGH SCORE 100 POST-OPERATIVE MORBIDITY (%) A B C Child-Pugh class Telem et al., Clin Gastroenterol Hepatol, 2010
12 PREDICTION OF SURGICAL RISK IN CIRRHOSIS MELD SCORE RELATIONSHIP BETWEEN MELD AND POST-OPERATIVE MORTALITY 30 days 90 days Teh et al., Gastroenterology, 2007
13 PREDICTION OF SURGICAL RISK IN CIRRHOSIS MELD SCORE POST-OPERATIVE MORBIDITY (%) <10 10 to to 25 >25 MELD SCORE Telem et al., Clin Gastroenterol Hepatol, 2010
14 PREDICTION OF SURGICAL RISK IN CIRRHOSIS EFFECT OF PORTAL HYPERTENSION A NATIONWIDE COHORT STUDY - ELECTIVE SURGERY IN-HOSPITAL MORTALITY Controls (n= ) Cirrhosis (n=18.335) Cirrhosis with portal hypertension (n=4214) Csikesz et al., Am Coll Surg, 2008
15 PREDICTION OF SURGICAL RISK IN CIRRHOSIS PATIENT VARIABLES INFLUENCING OUTCOME American Society of Anesthesiology, 2010 hyponatremia (< 130 meq/l) low serum albumin (< mg/dl) serum creatinine serum bilirubin ascites etiology of cirrhosis older age ASA score > 2-3..
16 SURGICAL RISK IN CIRRHOSIS SEARCHING FOR A PREDICTION MODEL 772 patients with cirrhosis 426 consecutive patients: consecutive patients: Major surgery 586 patients: digestive (laparatomy) 107 patients: orthopedic 79 patients: cardiovascular Comparison with two control groups 562 cirrhotics seen as outpatients 303 cirrhotics undergone minor surgery (appendicectomy, herniorrhaphy, ) Teh et al., Gastroenterology, 2007
17 SURGICAL RISK IN CIRRHOSIS SEARCHING FOR A PREDICTION MODEL 3 months 1 year 3 years Teh et al., Gastroenterology, 2007
18 SURGICAL RISK IN CIRRHOSIS SEARCHING FOR A PREDICTION MODEL DETERMINANTS OF POSTOPERATIVE MORTALITY AT MULTIVARIATE ANALYSIS MELD SCORE (liver disease severity) ASA SCORE (co-morbidities) AGE Teh et al., Gastroenterology, 2007
19 SURGICAL RISK IN CIRRHOSIS MAYO CLINIC POSTOPERATIVE MORTALITY RISK MODEL Google: surgical risk cirrhosis
20 SURGICAL RISK IN CIRRHOSIS MAYO CLINIC POSTOPERATIVE MORTALITY RISK MODEL MELD day mortality: 6% 3-fold increase Google: surgical risk cirrhosis
21 SURGICAL RISK IN CIRRHOSIS MAYO CLINIC POSTOPERATIVE MORTALITY RISK MODEL LIMITATIONS OF THE STUDY Retrospective Selection bias: sicker patients deferred Most patients had platelet > / L and INR < 1.5 Only 58 out of 772 patients had MELD > 15 Most surgical procedures were intra-abdominal
22 SURGICAL RISK IN CIRRHOSIS RISK ACCORDING TO PATIENT VARIABLES CHILD A no portal hypertension CHILD A with portal hypertension CHILD B CHILD C MELD < 8/10 MELD 8/10 16/18 MELD > 16/18 POST-OPERATIVE MORTALITY RISK MODEL MAYO CLINIC
23 PATIENT TYPE OF SURGERY PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY
24 PREDICTION OF SURGICAL RISK IN CIRRHOSIS UMBILICAL HERNIA REPAIR A NATIONWIDE COHORT STUDY ( controls vs cirrhotic patients) Carbonell et al, Hernia, 2005
25 PREDICTION OF SURGICAL RISK IN CIRRHOSIS LAPAROSCOPIC COLECISTECTOMY META-ANALYSIS (351 cirrhotic patients) Puggioni and Wong, Liv Intern, J Am Coll Surg 2003
26 PREDICTION OF SURGICAL RISK IN CIRRHOSIS COLORECTAL SURGERY A NATIONWIDE COHORT STUDY ( controls vs cirrhotics without PH vs cirrhotics with PH) Control Cirrhosis without PH Cirrhosis with PH 35,8 Mortality (%) ,6 20, ,1 7,2 1,8 All Elective Non-elective Nguyen et al, Dis Colon Rectum, 2009
27 PREDICTION OF SURGICAL RISK IN CIRRHOSIS CARDIAC SURGERY REVIEW OF THE LITERATURE MORTALITY RISK Modi et al, Inter Cardiovascul Thorac Surg 2010
28 PREDICTION OF SURGICAL RISK IN CIRRHOSIS TYPE OF SURGERY Umbilical and inguinal hernia repair Colorectal surgery Gastrectomy Pancreatic surgery Cardiac surgery Laparoscopic colecistectomy Open colecistectomy Lung surgery Abdominal trauma Orthopedic surgery Laparoscopic Laparotomic Elective Emergency
29 SURGICAL RISK IN CIRRHOSIS RISK ACCORDING TO TYPE OF ELECTIVE SURGERY LOW INTERMEDIATE HIGH UNACCEPTABLE or UKNOWN Abdominal wall surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Laparoscopic colecistectomy CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Open abdomen surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Lung surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Orthopedic surgery CHILD A - no PTH CHILD A - PTH CHILD B CHILD C Cardiac surgery CHILD A - no PTH CHILD A - PTH CHILD B - off pump CHILD B - on pump CHILD C
30 PATIENT TYPE OF SURGERY PREDICTION OF RISK OF MORTALITY AND MORBIDITY AFTER NON-HEPATIC SURGERY EXPERTISE OF THE SURGICAL AND MEDICAL TEAM
31 PREDICTION OF SURGICAL RISK IN CIRRHOSIS HOW TO MINIMIZE RISK Availaibility of less invasive approaches: laparoscopic techniques mini-invasive surgical techniques interventional radiology operative endoscopy Specific surgical expertise with cirrhotic patients MULTIDISCIPLINARY APPROACH High skill surgeon Specific medical expertise in the management of the pre-, peri-, and post-operative periods with cirrhotic patients
32 GRAZIE PER L ATTENZIONE
Coinfezione HIV-HCV. Raffaele Bruno, MD. Department of Infectious Diseases, University of Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
Coinfezione HIV-HCV Raffaele Bruno, MD This program is supported by educational grants from Department of Infectious Diseases, University of Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
More informationFrancesco Vizzutti. Azienda Ospedaliero Universitaria Careggi, Firenze
Francesco Vizzutti Azienda Ospedaliero Universitaria Careggi, Firenze Il sottoscritto dichiara di non aver avuto negli ultimi dodici mesi conflitto d interesse in relazione a questa presentazione e che
More informationEvaluation and Prognosis of Patients with Cirrhosis
Evaluation and Prognosis of Patients with Cirrhosis Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded
More informationAfter the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH
After the Cure: Long-Term Management of HCV Liver Disease Norah A. Terrault, MD, MPH Professor of Medicine Department of Gastroenterology Director, Viral Hepatitis Center University of California San Francisco
More informationAcute on Chronic Liver Failure: Current Concepts. Disclosures
Acute on Chronic Liver Failure: Current Concepts Vandana Khungar, MD MSc Assistant Professor of Medicine University of Pennsylvania, Perelman School of Medicine September 20, 2015 None to declare Disclosures
More informationAssessing the risk of surgery in patients with liver disease
REVIEW CME CREDIT AMITABH SUMAN, MD VA Medical Center and Shands Hospital at University of Florida, Gainesville WILLIAM D. CAREY, MD Director, Center for Continuing Education; Department of Gastroenterology,
More informationPatterns of abnormal LFTs and their differential diagnosis
Patterns of abnormal LFTs and their differential diagnosis Professor Matthew Cramp South West Liver Unit and Peninsula Schools of Medicine and Dentistry, Plymouth Summary liver function / liver function
More informationCirrhosis and HCV. Jonathan Israel M.D.
Cirrhosis and HCV Jonathan Israel M.D. Outline Relationship of fibrosis and cirrhosisprevalence and epidemiology. Sequelae of cirrhosis Diagnosis of cirrhosis Effect of cirrhosis on efficacy of treatment
More informationHOW TO MANAGE A PATIENT ON SYSTEMIC CHEMOTHERAPY
15th AISF PRE-MEETING COURSE Treatment of hepatocellular carcinoma Rome, February 20th HOW TO MANAGE A PATIENT ON SYSTEMIC CHEMOTHERAPY Dott. Massimo Iavarone 1 Division of Gastroenterology Fondazione
More informationA 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation.
A 55 year old man with cirrhosis due to chronic hepatitis C (CHC) genotype 3a is referred for liver transplantation. Three years ago he was treated with 24 weeks of peginterferon alfa-2a (180 µg/wk, PEGIFN)
More informationECG may be indicated for patients with cardiovascular risk factors
eappendix A. Summary for Preoperative ECG American College of Cardiology/ American Heart Association, 2007 A1 2002 A2 European Society of Cardiology and European Society of Anaesthesiology, 2009 A3 Improvement,
More informationSurveillance for Hepatocellular Carcinoma
Surveillance for Hepatocellular Carcinoma Marion G. Peters, MD John V. Carbone, MD, Endowed Chair Professor of Medicine Chief of Hepatology Research University of California San Francisco Recorded on April
More informationTherapy of decompensated cirrhosis Pre-transplant for HBV and HCV
Therapy of decompensated cirrhosis Pre-transplant for HBV and HCV Universitätsklinikum Leipzig Thomas Berg Sektion Hepatologie Klinik und Poliklinik für Gastroenterologie und Rheumatologie Leber- und Studienzentrum
More informationPREVENTION OF HCC BY HEPATITIS C TREATMENT. Morris Sherman University of Toronto
PREVENTION OF HCC BY HEPATITIS C TREATMENT Morris Sherman University of Toronto Pathogenesis of HCC in chronic hepatitis C Injury cirrhosis HCC Injury cirrhosis HCC Time The Ideal Study Prospective randomized
More informationEnd Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012
End Stage Liver Disease: What is New? Marion Peters MD UCSF Berlin 2012 Natural History of ESLD Increasing liver fibrosis Development of HCC Chronic liver disease Compensated cirrhosis Decompensated cirrhosis
More informationApproach to Abnormal Liver Tests
Approach to Abnormal Liver Tests Naga P. Chalasani, MD, FACG Professor of Medicine and Cellular & Integrative Physiology Director, Division of Gastroenterology and Hepatology Indiana University School
More informationGuide to Abdominal or Gastroenterological Surgery Claims
What are the steps towards abdominal surgery? Investigation and Diagnosis It is very important that all necessary tests are undertaken to investigate the patient s symptoms appropriately and an accurate
More informationThe following should be current within the past 6 months:
EVALUATION Baseline Labs Obtain at time or prior to initial evaluation CBC with diff PT/INR CMP HCV Genotype (obtained PRIOR TO consult visit) HCV RNA (obtained PRIOR TO consult visit) Hep A IgG Hep BsAg,
More informationAssessment of risk for non-hepatic surgery in cirrhotic patients
Assessment of risk for non-hepatic in cirrhotic patients Prashant Bhangui 1, Alexis Laurent 2, Roland Amathieu 3, Daniel Azoulay 4, 1 Medanta Institute of Liver Transplantation and Regenerative Medicine,
More informationLiver Transplantation for Hepatocellular Carcinoma. John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco
Liver Transplantation for Hepatocellular Carcinoma John P. Roberts, MD Chief, Division of Transplant Service University of California, San Francisco Hepatocellular Carcinoma HCC is the 5th most common
More informationPATIENT CONSENT TO PROCEDURE - ROUX-EN-Y GASTRIC BYPASS
As a patient you must be adequately informed about your condition and the recommended surgical procedure. Please read this document carefully and ask about anything you do not understand. Please initial
More informationBURDEN OF LIVER DISEASE IN BRAZIL
BURDEN OF LIVER DISEASE IN BRAZIL Burden of Liver Disease in Europe Blachier et al. J Hepatol 58:593, 2013 Review of 260 epidemiologic studies of the 5 previous years Cirrhosis is responsible for 170.000
More informationAppendix G - Identification and Selection of Studies
FINAL Emergency framework for rationing of blood for massively bleeding patients during a red phase of a Appendix G - Identification and Selection of Studies Inclusion/Exclusion Criteria We included studies
More informationOriginal Article Laparoscopic Cholecystectomy Pak Armed Forces Med J 2015; 65(2): 252-56
Original Article Laparoscopic Cholecystectomy Pak Armed Forces Med J 2015; 65(2): 252-56 LAPAROSCOPIC CHOLECYSTECTOMY: A CLINICAL PRACTICE AUDIT Mannan Masud, Maqbool Ahmed*, Zafar Iqbal Gondal, Muhammad
More informationThe State of the Liver in the Adult Patient after Fontan Palliation
The State of the Liver in the Adult Patient after Fontan Palliation Fred Wu, M.D. Boston Adult Congenital Heart Service Boston Children s Hospital/Brigham & Women s Hospital 7 th National Adult Congenital
More informationSpecialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents
Specialty Excellence Award and America s 100 Best Hospitals for Specialty Care 2013-2014 Methodology Contents Introduction... 2 Specialty Excellence Award Determination... 3 America s 100 Best Hospitals
More informationManagement of hepatitis C: pre- and post-liver transplantation. Piyawat Komolmit Bangkok
Management of hepatitis C: pre- and post-liver transplantation Piyawat Komolmit Bangkok Liver transplantation and CHC Cirrhosis secondary to HCV is the leading cause of liver transplantation in the US
More informationOptimal Management of Splenic/Portal Vein Thrombosis. David Mauchley University of Colorado
Optimal Management of Splenic/Portal Vein Thrombosis David Mauchley University of Colorado Overview Portal Vein Thrombosis (PVT) Etiology Presentation/Clinical Aspects Diagnosis Management Cirrhotic vs.
More informationLenox Hill Hospital Department of Surgery General Surgery Goals and Objectives
Lenox Hill Hospital Department of Surgery General Surgery Goals and Objectives Medical Knowledge and Patient Care: Residents must demonstrate knowledge and application of the pathophysiology and epidemiology
More informationLamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease. From : New England Journal of Medicine
Lamivudine for Patients with hronic Hepatitis B and Advanced Liver Disease From : New England Journal of Medicine Volume 351:1521-1531, Number 15, Oct 7, 2004 馬 偕 紀 念 醫 院 一 般 內 科, 肝 膽 腸 胃 科 新 竹 分 院 陳 重
More informationNP/PA Clinical Hepatology Fellowship Summary of Year-Long Curriculum
OVERVIEW OF THE FELLOWSHIP The goal of the AASLD NP/PA Fellowship is to provide a 1-year postgraduate hepatology training program for nurse practitioners and physician assistants in a clinical outpatient
More informationUCLA Asian Liver Program
CLA Program Update Program Faculty Myron J. Tong, PhD, MD Professor of Medicine Hepatology Director, Asian Liver Program Surgery Ronald W. Busuttil, MD, PhD Executive Chair Department of Surgery Director,
More informationHepatocellular Carcinoma (HCC)
Abhishek Vadalia Introduction Chemoembolization is being used with increasing frequency in the treatment of solid hepatic tumors such as Hepatocellular Carinoma (HCC) & rare Cholangiocellular Carcinoma
More informationHEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION. Francis Yao, M.D.
UCSF TRANSPLANT CONFERENCE - 9/28/2012 HEPATOCELLULAR CARCINOMA (HCC) RESECTION VERSUS TRANSPLANTATION Francis Yao, M.D. Professor of Clinical Medicine and Surgery Medical Director, Liver Transplantation
More informationLeading the Way to Treat Liver Cancer
Leading the Way to Treat Liver Cancer Guest Expert: Sukru, MD Professor of Transplant Surgery Mario Strazzabosco, MD Professor of Internal Medicine www.wnpr.org www.yalecancercenter.org Welcome to Yale
More informationThe most serious symptoms of this stage are:
The Natural Progression of Hepatitis C The natural history of hepatitis C looks at the likely outcomes for people infected with the virus if there is no medical intervention. However, the process of trying
More informationEndoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy. M. Arvanitakis SRBG June 2009
Endoscopy and infection: Prevention of infection during endoscopy Treatment of infection by endoscopy M. Arvanitakis SRBG June 2009 Outline Antibiotic prophylaxis during endoscopy Upper GI endoscopy Lower
More informationLIVER TRANSPLANTATION IN ALAGILLE SYNDROME
LIVER TRANSPLANTATION IN ALAGILLE SYNDROME Ronald J. Sokol, MD Children s Hospital Colorado University of Colorado School of Medicine Treatment of Liver Disease in Improve bile flow ALGS Ursodeoxycholic
More informationSurgery in the Patient with Liver Disease
Surgery in the Patient with Liver Disease Jacqueline G. O Leary, MD, MPH a, Patrick S.Yachimski, MD, MPH b,c,d, Lawrence S. Friedman, MD e,f,g,h, * KEYWORDS Cirrhosis Surgery MELD score Child class Liver
More informationApproach to Abnormal Liver Tests
This Morning s Presentation Approach to Abnormal Liver Tests Hal F. Yee, Jr., M.D., Ph.D. Rice Distinguished Professor, UCSF Chief of Gastroenterology, SFGH hyee@medsfgh.ucsf.edu Clinical vignettes representing
More informationInformed Consent for Laparoscopic Vertical Sleeve Gastrectomy. Patient Name
Informed Consent for Laparoscopic Vertical Sleeve Gastrectomy Patient Name Please read this form carefully and ask about anything you may not understand. I consent to have a laparoscopic Vertical Sleeve
More informationAlcoholic Hepatitis (Teacher s Guide)
Thomas Ormiston, M.D. Updated 5/5/15 2007-2015, SCVMC Alcoholic Hepatitis (Teacher s Guide) (30 minutes) I. Objectives Recognize the signs and symptoms of alcoholic hepatitis Understand the treatment options
More informationColocutaneous Fistula. Disclosures
Colocutaneous Fistula Madhulika G. Varma MD Associate Professor Chief, Colorectal Surgery University of California, San Francisco Honoraria Applied Medical Covidien Disclosures 1 Colocutaneous Fistula
More informationRecommendations 8/14/2014. Hepatitis C Clinical Approach Primary Care. Purpose of Presentation. HCV Prevalence Year of Birth
Hepatitis C Clinical Approach Primary Care Dr. Vicki L. MIt McIntyre, FNP Tucson Gastroenterology Specialists Tucson, Arizona University of Phoenix Lead Faculty, Department of Nursing Tucson, Arizona Purpose
More informationCharacterisation of co-morbidities in patients with alcoholic liver disease and engaging them in treatment.
Characterisation of co-morbidities in patients with alcoholic liver disease and engaging them in treatment. Khairunnessa Rahman, Dheeraj Shukla, Leigh Dahlenburg, Andrew Bailey, Robert Gribble, Paul Haber
More informationCirrhosis of liver: Etiological factors, complications and prognosis
Original Article Cirrhosis of liver: Etiological factors, complications and prognosis Suhail Ahmed Almani, A. Sattar Memon, Amir Iqbal Memon, M. Iqbal Shah, M. Qasim Rahpoto, Rahim Solangi ABSTRACT OBJECTIVE:
More informationChapter 6 Gastrointestinal Impairment
Chapter 6 Gastrointestinal This chapter consists of 2 parts: Part 6.1 Diseases of the digestive system Part 6.2 Abdominal wall hernias and obesity PART 6.1: DISEASES OF THE DIGESTIVE SYSTEM Diseases of
More informationNational Health Burden of CLD in Italy
National Health Burden of CLD in Italy 11,000 deaths due to liver cirrhosis or HCC in 2006 Direct costs for the National Health System for treating CLD patients: 420 M / year for hospital care 164 M /
More informationEBM DELL ERNIA OMBELICALE
U.O. Chirurgia Generale Ospedale Campostaggia Poggibonsi Primario Dott. Alessandro BIANCHI EBM DELL ERNIA OMBELICALE Dott. Massimo RANALLI It is unwise to be too sure of one s own wisdom. It is healthy
More informationHepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs
Last update: February 23, 2015 Hepatitis C Treatment Criteria Commercial & Minnesota Health Care Programs Please see healthpartners.com for Medicare coverage criteria. Table of Contents 1. Harvoni 2. Sovaldi
More informationCardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg
Cardiac Assessment for Renal Transplantation: Pre-Operative Clearance is Only the Tip of the Iceberg 2 nd Annual Duke Renal Transplant Symposium March 1, 2014 Durham, NC Joseph G. Rogers, M.D. Associate
More informationWhat to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic
What to Do with the Patient With Abnormal Liver Enzymes? Nizar N. Zein, M.D. The Cleveland Clinic Introduction Elevated liver enzymes is often not a clinical problem by itself. However it is a warning
More informationHCV/HIVCo-infection A case study by. Dominic Côté, Nurse Clinician B.Sc Chronic Viral Illness Services McGill University Health Centre
HCV/HIVCo-infection A case study by Dominic Côté, Nurse Clinician B.Sc Chronic Viral Illness Services McGill University Health Centre Objectives By sharing a case study of a patient co-infected with HIV/HCV
More informationLIVER FUNCTION TESTS AND STATINS
LIVER FUNCTION TESTS AND STATINS Philippe J. Zamor and Mark W. Russo Current Opinion in Cardiology 2011,26:338 341 SUMMARY Purpose of review: To discuss recent data on statins in patients with elevated
More informationC A R O L I N A S. Hernia Handbook ( C H A P T E R 2 ) B. Todd Heniford, MD
C A R O L I N A S Hernia Handbook ( C H A P T E R 2 ) B. Todd Heniford, MD C H A P T E R 2 Umbilical Hernias C A R O L I N A S H E R N I A H A N D B O O K 17 Umbilical Hernias W H AT I S A N U M B I L
More informationMANAGEMENT OF LIVER CIRRHOSIS
MANAGEMENT OF LIVER CIRRHOSIS Information Leaflet Your Health. Our Priority. Page 2 of 6 What is cirrhosis? Cirrhosis is a result of long-term, continuous damage to the liver and may be due to many different
More informationLaparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions
Laparoscopic Surgery of the Colon and Rectum (Large Intestine) A Simple Guide to Help Answer Your Questions What are the Colon and Rectum? The colon and rectum together make up the large intestine. After
More informationLiver, Gallbladder and Pancreas diseases. Premed 2 Pathophysiology
Liver, Gallbladder and Pancreas diseases Premed 2 Pathophysiology Pancreas Pancreatitis Acute Pancreatitis Autodigestion of the pancreas due to activation of the enzymes Hemorrhagic fat necrosis, calcium
More informationBile Duct Diseases and Problems
Bile Duct Diseases and Problems Introduction A bile duct is a tube that carries bile between the liver and gallbladder and the intestine. Bile is a substance made by the liver that helps with digestion.
More informationStudy of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis
Research Article Study of Effects of Probiotic Lactobacilli in Preventing Major Complications in Patients of Liver Cirrhosis RR. Pawar*, ML. Pardeshi and BB. Ghongane Department of Pharmacology, B.J. Medical
More informationLaparoscopic Gallbladder Removal (Cholecystectomy) Patient Information from SAGES
Laparoscopic Gallbladder Removal (Cholecystectomy) Patient Information from SAGES Gallbladder removal is one of the most commonly performed surgical procedures. Gallbladder removal surgery is usually performed
More informationSURGICAL PREAMBLE SPECIFIC ELEMENTS SURGICAL SERVICES WHICH ARE NOT LISTED AS A "Z" CODE
Surgical PreambleApril 1, 2015 PREAMBLE SPECIFIC ELEMENTS In addition to the common elements, all surgical services include the following specific elements. A. Supervising the preparation of and/or preparing
More informationPreoperative drainage is always indicated in malignant CBD strictures PRO. Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany
Preoperative drainage is always indicated in malignant CBD strictures PRO Horst Neuhaus Evangelisches Krankenhaus Düsseldorf, Germany Background Jaundice is associated with high perioperative morbidity
More informationBariatric i Surgery: Optimalizing Outcome Results. Dr. B. Dillemans AZ Sint-Jan AV Brugge-Oostende BARIATRIC SURGERY
Bariatric i Surgery: Optimalizing i Outcome Results Dr. B. Dillemans AZ Sint-Jan AV Brugge-Oostende THE OBESE PATIENT : A CHALLENGE FOR ANAESTHESIA, Ostend,14/11/09 BARIATRIC SURGERY 50 s : First Reported
More informationSurgical Site Infection Prevention
Surgical Site Infection Prevention 1 Objectives 1. Discuss risk factors for SSI 2. Describe evidence-based best practices for SSI prevention 3. State principles of antibiotic prophylaxis 4. Discuss novel
More informationBariatric Surgery: What the Internist Needs to Know
Bariatric Surgery: What the Internist Needs to Know Richard Stahl, MD, FACS Assistant Professor of Surgery Medical Director of Bariatric Surgery Disclosures None (sadly) Objectives Describe several myths
More informationObesity Affects Quality of Life
Obesity Obesity is a serious health epidemic. Obesity is a condition characterized by excessive body fat, genetic and environmental factors. Obesity increases the likelihood of certain diseases and other
More informationLedipasvir/Sofosbuvir (Harvoni) for Treatment of Hepatitis C
Ledipasvir/Sofosbuvir (Harvoni) for Treatment of Hepatitis C Policy Number: Original Effective Date: MM.04.034 12/1/2014 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST Integration 12/1/2014
More informationThe digestive system. Medicine and technology. Normal structure and function Diagnostic methods Example diseases and therapies
The digestive system Medicine and technology Normal structure and function Diagnostic methods Example diseases and therapies The digestive system An overview (1) Oesophagus Liver (hepar) Biliary system
More informationHepatocellular Carcinoma: What the hepatologist wants to know
Hepatocellular Carcinoma: What the hepatologist wants to know Hélène Castel, MD Liver Unit Hôpital St-Luc CHUM? CAR Annual Scientific Meeting Saturday, April 27 th 2013 Disclosure statement I do not have
More informationObjectives. Preoperative Cardiac Risk Stratification for Noncardiac Surgery. History
Preoperative Cardiac Risk Stratification for Noncardiac Surgery Kimberly Boddicker, MD FACC Essentia Health Heart and Vascular Center 27 th Heart and Vascular Conference May 13, 2011 Objectives Summarize
More informationPRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT
PRIOR AUTHORIZATION PROTOCOL FOR HEPATITIS C TREATMENT HARVONI (90mg ledipasvir/400mg sofosbuvir): tablet (PREFERRED AGENT) SOVALDI (sofosbuvir ): 400mg tablets (PREFERRED AGENT ) OLYSIO (simeprivir) PEG-INTRON
More informationClinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy
Clinical Case n. 3 Massimo Puoti AO Ospedale Niguarda Ca Granda Milano, Italy Disclosures Member of advisory boards &/or speaker in own events &/or investigator in RCT &/or research grants &/or teacher
More informationTransmission of HCV in the United States (CDC estimate)
Transmission of HCV in the United States (CDC estimate) Past and Future US Incidence and Prevalence of HCV Infection Decline among IDUs Overall incidence Overall prevalence Infected 20+ years Armstrong
More informationDENOMINATOR: All patients aged 18 years and older with a diagnosis of chronic hepatitis C cirrhosis
Measure #401: Hepatitis C: Screening for Hepatocellular Carcinoma (HCC) in Patients with Cirrhosis National Quality Strategy Domain: Effective Clinical Care 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationHEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis
HEPATITIS WEB STUDY Acute C Virus Infection: Epidemiology, Clinical Features, and Diagnosis H. Nina Kim, MD Assistant Professor of Medicine Division of Infectious Diseases University of Washington School
More informationElective versus emergency surgery for ulcerative colitis: a National Surgical Quality Improvement Program analysis
The American Journal of Surgery (2013) 205, 333-338 Midwest Surgical Association Elective versus emergency surgery for ulcerative colitis: a National Surgical Quality Improvement Program analysis Supriya
More informationFacing a Hernia Repair? Learn about minimally invasive da Vinci Surgery
Facing a Hernia Repair? Learn about minimally invasive da Vinci Surgery The Condition: Hernia A hernia happens when part of an internal organ or tissue bulges through a hole or weak area in the belly wall
More informationINFORMED CONSENT FOR SLEEVE GASTRECTOMY
INFORMED CONSENT FOR SLEEVE GASTRECTOMY This informed-consent document has been prepared to help inform you about your Sleeve Gastrectomy including the risks and benefits, as well as alternative treatments.
More informationSpecific Standards of Accreditation for Residency Programs in General Surgery
Specific Standards of Accreditation for Residency Programs in General Surgery 2010 INTRODUCTION The purpose of this document is to provide program directors and surveyors with an interpretation of the
More informationAbnormal Liver Function. Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London
Abnormal Liver Function Dr William Alazawi MA(Cantab) PhD MRCP Senior Lecturer and Consultant in Hepatology Queen Mary, University of London Does Liver Disease Matter? Mortality in England & Wales Liver-related
More informationBowel Preparation for Colon Resection. Eric Klein, M.D. SUNY Downstate Department of Surgery
Bowel Preparation for Colon Resection Eric Klein, M.D. SUNY Downstate Department of Surgery Historical Perspective During World War II, failure to treat penetrating colon injuries with diversion could
More informationWhat to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon
What to do with abnormal LFTs? Andrew M Smith Hepatobiliary Surgeon "it looks like there's something wrong.with your television set. Matt Groenig, creator of The Simpsons Probability of an abnormal screening
More informationELSO GUIDELINES FOR ECMO CENTERS
ELSO GUIDELINES FOR ECMO CENTERS PURPOSE These guidelines developed by the Extracorporeal Life Support Organization, outline the ideal institutional requirements needed for effective use of extracorporeal
More informationHEPATOLOGY CLERKSHIP
College of Osteopathic Medicine HEPATOLOGY CLERKSHIP Office for Clinical Affairs 515-271-1629 FAX 515-271-1727 Elective Rotation General Description This elective rotation is a four (4) week introductory,
More informationAASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation
AASLD PRACTICE GUIDELINE AASLD Practice Guidelines: Evaluation of the Patient for Liver Transplantation Karen F. Murray and Robert L. Carithers, Jr. Preamble These recommendations provide a data-supported
More informationEpidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
More informationOverview of Bariatric Surgery
Overview of Bariatric Surgery To better understand how weight loss surgery works, it is helpful to know how the normal digestive process works. As food moves along the digestive tract, special digestive
More informationPerspective End-Stage Liver Disease in HIV Disease
Perspective End-Stage Liver Disease in HIV Disease Liver disease is the most common non AIDS-related cause of mortality in HIV-infected patients. HIV-infected patients with chronic liver disease progress
More informationEMR Decision Tool. Clinical and functional elements for EMR software
EMR Decision Tool Clinical and functional elements for EMR software AGA Institute EMR Clinical and Functional Elements EMR Decision Tool To assist gastroenterologists in the decision process needed to
More informationThe Natural History of Hepatitis C Cirrhosis After Liver Transplantation
LIVER TRANSPLANTATION 15:1063-1071, 2009 ORIGINAL ARTICLE The Natural History of Hepatitis C Cirrhosis After Liver Transplantation Roberto J. Firpi,* Virginia Clark,* Consuelo Soldevila-Pico, Giuseppe
More informationINFORMATION SHEET FOR A LAPAROSCOPIC SLEEVE GASTRECTOMY
INFORMATION SHEET FOR A LAPAROSCOPIC SLEEVE GASTRECTOMY You are considering undergoing a laparoscopic sleeve gastrectomy for weight loss. The purpose of this information sheet is to provide you with the
More informationBACKGROUND MEDIA INFORMATION Fast facts about liver disease
BACKGROUND MEDIA INFORMATION Fast facts about liver disease Liver, or hepatic, disease comprises a wide range of complex conditions that affect the liver. Liver diseases are extremely costly in terms of
More information23/06/2014. Nutrition in Chronic Liver Disease. Objectives. Question #1
Nutrition in Chronic Liver Disease Maitreyi Raman, MD, FRCPC Clinical Associate Professor University of Calgary April 2014 Objectives 1. Describe contributing factors toward malnutrition in advanced liver
More informationMachine learning of patient similarity: a case study on predicting survival in cancer patient after locoregional chemotherapy.
Title Machine learning of patient similarity: a case study on predicting survival in cancer patient after locoregional chemotherapy Author(s) Chan, LWC; Chan, T; Cheng, LF; Mak, WS Citation The 2010 IEEE
More informationLiver Diseases. An Essential Guide for Nurses and Health Care Professionals
Brochure More information from http://www.researchandmarkets.com/reports/1047385/ Liver Diseases. An Essential Guide for Nurses and Health Care Professionals Description: Liver disease is a rapidly growing
More informationHepatitis C Treatment Expansion Initiative Multi-Site Conference Call. March 16, 2011
Hepatitis C Treatment Expansion Initiative Multi-Site Conference Call March 16, 2011 Case Presentations Kansas City Free Health Clinic Carilion Clinic Didactic Session Challenges in Determining HCV Treatment
More informationClinical Practice Assessment Robotic surgery
Clinical Practice Assessment Robotic surgery Background: Surgery is by nature invasive. Efforts have been made over time to reduce complications and the trauma inherently associated with surgery through
More informationDr Alessandro Armuzzi, UOC di Medicina Interna e Gastroenterologia Complesso Integrato Columbus Università Cattolica
Dr Alessandro Armuzzi, UOC di Medicina Interna e Gastroenterologia Complesso Integrato Columbus Università Cattolica Il sottoscritto dichiara di non aver avuto negli ultimi 12 mesi conflitto d interesse
More information